ASX:MDR MedAdvisor (MDR) Stock Price, News & Analysis → Don’t Miss Out on the AI Gold Rush That’s Just Getting Started (From Banyan Hill Publishing) (Ad) Free MDR Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume719,064 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get MedAdvisor alerts: Email Address Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him About MedAdvisor Stock (ASX:MDR)MedAdvisor Limited, together with its subsidiaries, provides pharmacy-driven patient engagement solutions in Australia, New Zealand, the United States, and the United Kingdom. The company provides MedAdvisor, an extension of the pharmacy, that enables the patient to order repeat prescriptions, and schedule vaccinations, etc; and THRiV, an omni-channel intelligent patient management platform, that enables individualized patient engagement through the community pharmacy. MedAdvisor Limited was incorporated in 2010 and is based in Camberwell, Australia.Read More Ad Banyan Hill PublishingDon’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.See how you can invest alongside him MDR Stock News HeadlinesApril 10, 2024 | finance.yahoo.comShareholders in MedAdvisor (ASX:MDR) are in the red if they invested five years agoApril 8, 2024 | finanznachrichten.deThreatLocker Inc.: ThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the WorldApril 24, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.April 8, 2024 | finance.yahoo.comThreatLocker® Unveils New Managed Detection and Response (MDR) Service with the WorldMarch 29, 2024 | finance.yahoo.com4 Day Virtual Medical Device Software Compliance Course: Complying with the EU MDR, EU IVDR & FDA RegulationsMarch 21, 2024 | markets.businessinsider.comEQS-News: Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term SupplyMarch 12, 2024 | finance.yahoo.comESET Webinar Outlines How to Outsmart Cybercrime with MDRMarch 12, 2024 | finance.yahoo.comMedical Device Software Course: Complying with the EU MDR, EU IVDR & FDA Regulations - 4 Day Online Event, July 22-25, 2024April 24, 2024 | Banyan Hill Publishing (Ad)Don’t Miss Out on the AI Gold Rush That’s Just Getting Started“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.March 11, 2024 | finance.yahoo.comColdZyme® certified under the new EU medical device regulation (MDR)March 11, 2024 | finance.yahoo.comPulseCath Achieves MDR CE Certification for iVAC 2L, Paving the Way for Complex High-Risk Percutaneous Coronary InterventionsMarch 11, 2024 | finanznachrichten.deEnzymatica AB: ColdZyme® certified under the new EU medical device regulation (MDR)February 29, 2024 | finance.yahoo.comManaged Detection and Response (MDR) Market Worth $9.5 billion by 2028, Growing At a CAGR of 23.3% Report by MarketsandMarkets™February 27, 2024 | finance.yahoo.comBEN and MedAdvisor Solutions Team Up to Bring Conversational AI to Patients Through PharmaciesFebruary 27, 2024 | finance.yahoo.comThreatHunter.ai Unveils Special Offer for Carbon Black MDR Customers Seeking Swift and Secure MigrationFebruary 8, 2024 | finance.yahoo.comCSOFT Health Sciences Releases MDR White Paper to Support EU Medical Device ComplianceFebruary 8, 2024 | finance.yahoo.comZOLL One of the First to Receive Approval for AEDs Under the EU Medical Device Regulation (MDR) CertificationFebruary 5, 2024 | msn.comHigh risk devices can be exempted from mandatory trials under EU MDRJanuary 24, 2024 | msn.comMDR Commissioner says tax revenues continue to show growthJanuary 22, 2024 | msn.com1MED prepares to unveil EU MDR compliance softwareJanuary 11, 2024 | msn.comHow is Europe’s MedTech industry navigating the EU MDR?January 8, 2024 | finance.yahoo.comInstitutions profited after MedAdvisor Limited's (ASX:MDR) market cap rose AU$41m last week but private companies profited the mostDecember 21, 2023 | msn.comJUNE Medical’s Galaxy II® self-retaining surgical retractor receives MDR certification for its high quality and safetyDecember 18, 2023 | tmcnet.com"Sophos MDR is a Must" and Sophos Intercept X is "A Real Threat for Hackers," Say Sophos Customers in G2's Peer-to-Peer Winter 2024 ReportDecember 18, 2023 | markets.businessinsider.comRevolutionary AI Algorithm «Prostate.Carcinoma.ai» Achieves EU MDR Class IIa RegistrationDecember 4, 2023 | benzinga.comSophos Managed Detection and Response (MDR) Named CRN Product of the YearNovember 28, 2023 | finance.yahoo.comCHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO DRIVE ITS INTERNATONAL GROWTHSee More Headlines Receive MDR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MedAdvisor and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Health Information Services Sub-IndustryN/A Current SymbolASX:MDR CUSIPN/A CIKN/A Webwww.medadvisor.com.au Phone61 3 9095 3036FaxN/AEmployees31,900Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.02) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,030,000.00 Net Margins-8.25% Pretax MarginN/A Return on Equity-15.21% Return on Assets-2.39% Debt Debt-to-Equity Ratio22.65 Current Ratio0.87 Quick Ratio0.47 Sales & Book Value Annual Sales$109.43 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow7.95 Book ValueA$0.10 per share Price / BookN/AMiscellaneous Outstanding Shares550,150,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.66 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Richard RatliffCEO, MD & DirectorMs. Ancila Desai B.Com.C.A., M.B.A., CFO & Joint Company SecretaryMr. Craig SchnurigerActing Chief Technology OfficerMr. James M. Rotsart R.Ph.Executive VP of US & Client RelationsMr. Wayne MarinoffPresident of ANZMs. Anshu RaghuvanshiJoint Company SecretaryMore ExecutivesKey Competitors1st GroupASX:1STAclarionNASDAQ:ACONWAlcidion GroupASX:ALCArcturis DataOTCMKTS:SSYNFArtryaASX:AYAView All CompetitorsInsidersJim XenosSold 6,846,955 sharesTotal: $1.23 M ($0.18/share) This page (ASX:MDR) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingThe #1 Crypto for 2024InvestorPlaceThe Greatest Bull Market in Crypto History…Weiss RatingsMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MedAdvisor Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
